LD-2 disclosure · 1st Quarter - Report
TETRAPHASE PHARMACEUTICALS
Income$10Kfee reported
Client
- Description
- Creating novel antibiotics or serious and life threatening MDR infections.
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - "DISARM Act of 2015."
LobbyistsJOHN MCMANUS · LINDSAY BEALOR · BARRETT THORNHILL · CHASE M THOMAS
TargetedSENATE · HOUSE OF REPRESENTATIVES